These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17096683)

  • 21. Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects.
    Caraco Y; Sheller J; Wood AJ
    J Pharmacol Exp Ther; 1999 Jul; 290(1):413-22. PubMed ID: 10381807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic susceptibility to acquired long QT syndrome: pharmacologic challenge in first-degree relatives.
    Kannankeril PJ; Roden DM; Norris KJ; Whalen SP; George AL; Murray KT
    Heart Rhythm; 2005 Feb; 2(2):134-40. PubMed ID: 15851285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.
    Darpo B; Karnad DR; Badilini F; Florian J; Garnett CE; Kothari S; Panicker GK; Sarapa N
    Br J Clin Pharmacol; 2014 Mar; 77(3):522-31. PubMed ID: 23819796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.
    Kannankeril PJ; Norris KJ; Carter S; Roden DM
    Heart Rhythm; 2011 Oct; 8(10):1530-4. PubMed ID: 21420510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model-based evaluation of drug-induced QTc prolongation for compounds in early development.
    Dubois VF; Yu H; Danhof M; Della Pasqua O;
    Br J Clin Pharmacol; 2015 Jan; 79(1):148-61. PubMed ID: 25099645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program.
    Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Walroth TA; Ott CA; Desta Z; Williams G; Moe PR; Wilbrandt M; Tisdale JE
    Pharmacotherapy; 2021 Mar; 41(3):238-246. PubMed ID: 33345336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
    Roden DM; Woosley RL; Primm RK
    Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro to human in vivo translation - pharmacokinetics and pharmacodynamics of quinidine.
    Polak S
    ALTEX; 2013; 30(3):309-18. PubMed ID: 23861085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs.
    Ollerstam A; Visser SA; Persson AH; Eklund G; Nilsson LB; Forsberg T; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A
    J Pharmacol Toxicol Methods; 2006; 53(2):174-83. PubMed ID: 16140023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in rats.
    Ohtani H; Hanada E; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1996 Sep; 19(9):1189-96. PubMed ID: 8889039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diseases and drugs causing prolongation of the QT interval.
    Laakso M; Aberg A; Savola J; Pentikäinen PJ; Pyörälä K
    Am J Cardiol; 1987 Apr; 59(8):862-5. PubMed ID: 3825950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathetic activation enhances QT prolongation by quinidine.
    Darbar D; Fromm MF; Dellorto S; Roden DM
    J Cardiovasc Electrophysiol; 2001 Jan; 12(1):9-14. PubMed ID: 11204091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Itraconazole increases plasma concentrations of quinidine.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers.
    Min DI; Ku YM; Geraets DR; Lee H
    J Clin Pharmacol; 1996 May; 36(5):469-76. PubMed ID: 8739026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Nemonoxacin on Thorough ECG QT/QTc Interval: A Randomized, Placebo- and Positive-controlled Crossover Study in Healthy Chinese Adults.
    Zhao C; Lv Y; Li X; Hou F; Ma X; Wei M; Kang Z; Cui L; Xia Y; Liu Y; Tian J
    Clin Ther; 2018 Jun; 40(6):983-992. PubMed ID: 29803534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thorough QT/QTc Study Shows That a Novel 5-HT
    Hamatani T; Noda N; Takagaki T; Yodo Y; Kawai H; Kakuyama H; Kaji Y; Fujio Y
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):938-951. PubMed ID: 32087003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
    Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
    Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex difference in the relationship between insulin resistance and corrected QT interval in non-diabetic subjects.
    Shin HS; Lee WY; Kim SW; Jung CH; Rhee EJ; Kim BJ; Sung KC; Kim BS; Kang JH; Lee MH; Park JR
    Circ J; 2005 Apr; 69(4):409-13. PubMed ID: 15791034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole?
    Cooke CE; Sklar GE; Nappi JM
    Ann Pharmacother; 1996 Apr; 30(4):364-6. PubMed ID: 8729890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.